Skip to main content
RELMADA THERAPEUTICS, INC. logo

RELMADA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · RLMD ISIN · US75954H1005 LEI · 549300217EASRZ9JSF81 US Professional, scientific and technical activities
Open in API
Filings indexed 582 across all filing types
Latest filing 2014-07-01 Major Shareholding Noti…
Country US United States of America
Listing US RLMD

About RELMADA THERAPEUTICS, INC.

https://www.relmada.com/

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company developing novel therapies. The company's lead program is NDV-01, a sustained-release, intravesical formulation of gemcitabine and docetaxel for the treatment of non-muscle invasive bladder cancer. The formulation is designed for gradual drug release over 10 days to enhance local exposure and minimize systemic toxicity. Relmada's pipeline also includes Sepranolone, which is being developed for compulsive disorders. Following positive proof-of-concept data in Tourette’s syndrome, the company is planning a Phase 2 study of Sepranolone in Prader-Willi Syndrome, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification
2014-07-01 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes detailed information about the company, securities being registered, risk factors, business overview, management discussion, and financial statements. This type of filing is related to capital raising and securities registration, not an annual report, earnings release, or other types of filings. The closest matching category in the provided list is 'Capital/Financing Update (CAP)', which covers updates on company fundraising and financing activities. Therefore, the document should be classified as a Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, confirming it is not merely an announcement but the actual registration statement.
2014-06-30 English
Regulatory Filings 2014
Regulatory Filings
2014-06-19 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 10, 2014. It details the completion of a material definitive agreement involving the sale of securities, including common stock and warrants, and related agreements such as the Investor Rights Agreement and lock-up agreements. The content focuses on financing activities, including the sale of shares and warrants, proceeds received, and terms of the agreements. There are no financial statements or comprehensive financial performance data presented, nor is this an announcement of voting results, management changes, or legal proceedings. The primary subject is the company's capital raising transaction and related agreements. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length (8048 characters) and detailed description of the financing transaction support this classification with high confidence.
2014-06-16 English
Regulatory Filings 2014
Regulatory Filings
2014-06-04 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 30, 2014. The content focuses on an amendment to the Articles of Incorporation to increase the authorized shares of common and preferred stock. There are no financial statements or detailed financial data included, only a description of a corporate governance change related to capital structure. The document is relatively short (2824 characters) and includes an exhibit of the amendment. This type of filing is best classified as a Capital/Financing Update (CAP) because it relates to changes in the company's capital structure (increase in authorized shares). It is not an Annual Report, Interim Report, or Earnings Release, nor is it a simple announcement of a report publication. Therefore, the appropriate classification is CAP with high confidence.
2014-06-02 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.